Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

2 terminated/withdrawn out of 20 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

N/A
7(50.0%)
Phase 2
4(28.6%)
Phase 3
2(14.3%)
Phase 1
1(7.1%)
14Total
N/A(7)
Phase 2(4)
Phase 3(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT06200974Recruiting

Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

Role: collaborator

NCT03426748Not ApplicableActive Not Recruiting

LDR vs. HDR Brachytherapy for Prostate Cancer

Role: collaborator

NCT01936883Not ApplicableActive Not Recruiting

Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy

Role: collaborator

NCT06574620Not ApplicableRecruiting

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Role: collaborator

NCT02155621Not ApplicableRecruiting

Personalized Oncogenomics (POG) Program of British Columbia

Role: collaborator

NCT02869802Recruiting

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

Role: collaborator

NCT03385655Phase 2Active Not Recruiting

Prostate Cancer Biomarker Enrichment and Treatment Selection

Role: collaborator

NCT06862323Phase 2Not Yet Recruiting

Time Restricted Eating in Haematological Malignancies

Role: collaborator

NCT03031821Phase 3Terminated

Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome

Role: collaborator

NCT05708326Not ApplicableCompleted

A Case Crossover Study of Intermittent Fasting in CLL/SLL

Role: collaborator

NCT04626843Phase 1Completed

Intermittent Fasting and CLL/SLL

Role: collaborator

NCT04141397Unknown

Real-world Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer Care

Role: collaborator

NCT01384877Phase 2Completed

Subcutaneous Lidocaine For Cancer-Related Pain

Role: collaborator

NCT02978547Phase 2Unknown

The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma

Role: collaborator

NCT03202810Unknown

Innovative Approach to Triage Oral Precancer

Role: collaborator

NCT02171286Completed

The Oncopanel Pilot (TOP) Study

Role: collaborator

NCT01422928Phase 3Withdrawn

Acupuncture for the Immune System in Radiation Cancer Patients

Role: collaborator

NCT01802905Not ApplicableCompleted

Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies

Role: collaborator

NCT01719068Unknown

Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos

Role: collaborator

NCT01191164Not ApplicableUnknown

Pilot Study of Partial Breast Irradiation Utilizing Permanent Breast Seed Implant to Treat Breast Cancer

Role: collaborator

All 20 trials loaded